Voriconazole-induced periostitis in stem cell transplant patient

被引：0

作者：

Alexandre E. Malek

Yara Skaff

Victor E. Mulanovich

机构：

[1] The University of Texas MD Anderson Cancer Center,Department of Infectious Diseases, Infection Control and Employee Health

[2] University of Texas Health Science Center At Houston,Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School

[3] The Gilbert and Rose-Marie Chagoury School of Medicine,Department of Internal Medicine

[4] Lebanese American University,undefined

来源：

Infection | 2020年 / 48卷

关键词：

Voriconazole; Periostitis; Stem cell transplant;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：809 / 810

页数：1

共 19 条

[1]

Wermers RA(2011)Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy Clin Infect Dis 52 604-611

[2]

Cooper K(2013)Voriconazole-induced periostitis in two post-transplant patients J Radiol Case Rep 7 10-637

[3]

Razonable RR(2003)Voriconazole: a new triazole antifungal agent Clin Infect Dis 36 630-583

[4]

Bucknor MD(2016)Correlation of pain and fluoride concentration in allogeneic hematopoietic stem cell transplant recipients on voriconazole Biol Blood Marrow Transpl 22 579-1245

[5]

Gross AJ(2014)Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain Clin Infect Dis 59 1237-2394

[6]

Link TM(2012)Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole Blood 120 2390-1386

[7]

Johnson LB(2016)Adverse effects of voriconazole: over a decade of use Clin Transpl 30 1377-undefined

[8]

Kauffman CA(undefined)undefined undefined undefined undefined-undefined

[9]

Barajas MR(undefined)undefined undefined undefined undefined-undefined

[10]

McCullough KB(undefined)undefined undefined undefined undefined-undefined

← 1 2 →